Xebio Holdings Co., Ltd.
TSE:8281.T
1175 (JPY) • At close September 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) JPY.
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Revenue
| 250,603 | 242,433 | 239,293 | 223,282 | 202,438 |
| Cost of Revenue
| 158,371 | 149,546 | 147,519 | 136,228 | 123,618 |
| Gross Profit
| 92,232 | 92,887 | 91,774 | 87,054 | 78,820 |
| Gross Profit Ratio
| 0.368 | 0.383 | 0.384 | 0.39 | 0.389 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 78,343 | 76,891 | 73,634 | 72,389 | 67,539 |
| Selling & Marketing Expenses
| 6,882 | 7,401 | 6,372 | 6,194 | 5,001 |
| SG&A
| 85,225 | 84,292 | 80,006 | 78,583 | 72,540 |
| Other Expenses
| 0 | 4,391 | 3,440 | 3,471 | 3,513 |
| Operating Expenses
| 85,225 | 88,683 | 83,446 | 82,054 | 76,053 |
| Operating Income
| 7,007 | 4,204 | 8,327 | 4,999 | 2,767 |
| Operating Income Ratio
| 0.028 | 0.017 | 0.035 | 0.022 | 0.014 |
| Total Other Income Expenses Net
| -3,930 | 317 | 509 | 1,215 | 328 |
| Income Before Tax
| 3,077 | 4,521 | 8,836 | 6,214 | 3,095 |
| Income Before Tax Ratio
| 0.012 | 0.019 | 0.037 | 0.028 | 0.015 |
| Income Tax Expense
| 2,098 | 1,789 | 3,241 | 2,361 | 2,681 |
| Net Income
| 971 | 2,592 | 5,397 | 3,836 | 412 |
| Net Income Ratio
| 0.004 | 0.011 | 0.023 | 0.017 | 0.002 |
| EPS
| 22.6 | 58.63 | 122.07 | 86.77 | 9.32 |
| EPS Diluted
| 22.44 | 58.32 | 121.57 | 86.44 | 9.29 |
| EBITDA
| 9,114 | 9,718 | 12,967 | 9,247 | 7,678 |
| EBITDA Ratio
| 0.036 | 0.04 | 0.054 | 0.041 | 0.038 |